Titre : 2-Cyano-acrylate d'isobutyle

2-Cyano-acrylate d'isobutyle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Pilot Projects
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "2-Cyano-acrylate d'isobutyle : Questions médicales les plus fréquentes", "headline": "2-Cyano-acrylate d'isobutyle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les 2-Cyano-acrylate d'isobutyle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-15", "dateModified": "2025-04-09", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Enbucrilate", "url": "https://questionsmedicales.fr/mesh/D004659", "about": { "@type": "MedicalCondition", "name": "Enbucrilate", "code": { "@type": "MedicalCode", "code": "D004659", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.637.051.919.367.341" } } }, "about": { "@type": "MedicalCondition", "name": "2-Cyano-acrylate d'isobutyle", "alternateName": "Bucrylate", "code": { "@type": "MedicalCode", "code": "D002015", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Michael Schultheiß", "url": "https://questionsmedicales.fr/author/Michael%20Schulthei%C3%9F", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Max Giesler", "url": "https://questionsmedicales.fr/author/Max%20Giesler", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lars Maruschke", "url": "https://questionsmedicales.fr/author/Lars%20Maruschke", "affiliation": { "@type": "Organization", "name": "Department of Radiology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Arthur Schmidt", "url": "https://questionsmedicales.fr/author/Arthur%20Schmidt", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } }, { "@type": "Person", "name": "Lukas Sturm", "url": "https://questionsmedicales.fr/author/Lukas%20Sturm", "affiliation": { "@type": "Organization", "name": "Department of Gastroenterology, University Hospital of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.", "datePublished": "2022-09-12", "url": "https://questionsmedicales.fr/article/36097245", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.17269/s41997-022-00691-z" } }, { "@type": "ScholarlyArticle", "name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.", "datePublished": "2023-03-30", "url": "https://questionsmedicales.fr/article/37047951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20075336" } }, { "@type": "ScholarlyArticle", "name": "Global pen pal education intervention among student pharmacists: A pilot project.", "datePublished": "2022-09-22", "url": "https://questionsmedicales.fr/article/36153244", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cptl.2022.09.020" } }, { "@type": "ScholarlyArticle", "name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.", "datePublished": "2024-09-27", "url": "https://questionsmedicales.fr/article/39457265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph21101292" } }, { "@type": "ScholarlyArticle", "name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.", "datePublished": "2023-02-16", "url": "https://questionsmedicales.fr/article/36798046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/00031348231157833" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Produits manufacturés", "item": "https://questionsmedicales.fr/mesh/D008420" }, { "@type": "ListItem", "position": 4, "name": "Matériaux biomédicaux et dentaires", "item": "https://questionsmedicales.fr/mesh/D001697" }, { "@type": "ListItem", "position": 5, "name": "Adhésifs tissulaires", "item": "https://questionsmedicales.fr/mesh/D014014" }, { "@type": "ListItem", "position": 6, "name": "Cyanoacrylates", "item": "https://questionsmedicales.fr/mesh/D003487" }, { "@type": "ListItem", "position": 7, "name": "Enbucrilate", "item": "https://questionsmedicales.fr/mesh/D004659" }, { "@type": "ListItem", "position": 8, "name": "2-Cyano-acrylate d'isobutyle", "item": "https://questionsmedicales.fr/mesh/D002015" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : 2-Cyano-acrylate d'isobutyle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur 2-Cyano-acrylate d'isobutyle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur 2-Cyano-acrylate d'isobutyle", "description": "Comment le Bucrylate est-il utilisé en diagnostic ?\nQuels tests sont nécessaires avant d'utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur 2-Cyano-acrylate d'isobutyle", "description": "Quels symptômes peuvent survenir après l'application de Bucrylate ?\nLe Bucrylate peut-il provoquer des douleurs ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur 2-Cyano-acrylate d'isobutyle", "description": "Comment prévenir les réactions allergiques au Bucrylate ?\nQuelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur 2-Cyano-acrylate d'isobutyle", "description": "Le Bucrylate est-il utilisé pour traiter des infections ?\nComment le Bucrylate favorise-t-il la cicatrisation ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur 2-Cyano-acrylate d'isobutyle", "description": "Quelles complications peuvent survenir avec le Bucrylate ?\nLe Bucrylate peut-il causer des réactions systémiques ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur 2-Cyano-acrylate d'isobutyle", "description": "Qui est à risque d'allergie au Bucrylate ?\nLes enfants peuvent-ils utiliser le Bucrylate ?", "url": "https://questionsmedicales.fr/mesh/D002015?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment le Bucrylate est-il utilisé en diagnostic ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Il n'est pas utilisé pour le diagnostic, mais pour la fermeture des plaies." } }, { "@type": "Question", "name": "Quels tests sont nécessaires avant d'utiliser le Bucrylate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Aucun test spécifique n'est requis, mais l'historique allergique doit être vérifié." } }, { "@type": "Question", "name": "Quels symptômes peuvent survenir après l'application de Bucrylate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des rougeurs, démangeaisons ou gonflements peuvent apparaître au site d'application." } }, { "@type": "Question", "name": "Le Bucrylate peut-il provoquer des douleurs ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs légères peuvent survenir, mais elles sont généralement temporaires." } }, { "@type": "Question", "name": "Comment prévenir les réactions allergiques au Bucrylate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Évaluer l'historique allergique et effectuer un test cutané si nécessaire." } }, { "@type": "Question", "name": "Quelles précautions doivent être prises lors de l'utilisation du Bucrylate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le contact avec les yeux et les muqueuses, et utiliser dans un environnement stérile." } }, { "@type": "Question", "name": "Le Bucrylate est-il utilisé pour traiter des infections ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, il est utilisé pour la fermeture des plaies, pas pour traiter les infections." } }, { "@type": "Question", "name": "Comment le Bucrylate favorise-t-il la cicatrisation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Il forme une barrière protectrice qui aide à maintenir l'humidité et à réduire l'infection." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec le Bucrylate ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des infections, des réactions allergiques ou des cicatrices anormales peuvent survenir." } }, { "@type": "Question", "name": "Le Bucrylate peut-il causer des réactions systémiques ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions systémiques sont rares, mais possibles en cas d'allergie sévère." } }, { "@type": "Question", "name": "Qui est à risque d'allergie au Bucrylate ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies aux adhésifs ou aux cyanoacrylates." } }, { "@type": "Question", "name": "Les enfants peuvent-ils utiliser le Bucrylate ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, mais avec prudence et sous supervision médicale en raison de leur peau sensible." } } ] } ] }

Sources (10000 au total)

SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.

Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro... An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p... A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple... This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...

Global pen pal education intervention among student pharmacists: A pilot project.

Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim... This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm... In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...

Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.

In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan... Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and... The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...

Community-supported teaching on the topic of transgender identity in undergraduate medical education - a pilot project.

Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab... During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ... The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga... One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...

Assessing tenant health amid social housing redevelopment: lessons from a pilot project.

To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th... Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,... A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported.... This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...

Developing a trigger tool to monitor adverse events during haemodialysis in children: a pilot project.

We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events.... Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a... There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions... This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...

vSEMERA: pilot project assessing health profession students' experiences in an international virtual research program.

The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho... vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a... The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche... vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...